Abbott Laboratories (NYSE:ABT)

62.37
Delayed Data
As of May 25
 -0.14 / -0.22%
Today’s Change
43.44
Today|||52-Week Range
64.60
+9.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues20.2B20.4B20.9B27.4B
 
 
 
 
 
Cost of Goods Sold8.2B8.0B8.3B11.2B
 
 
 
 
 
Depreciation And Amortization1.5B1.5B1.4B3.0B
 
 
 
 
 
 
Operating ExpensesGross Income10.5B11.0B11.2B13.1B
 
 
 
 
 
General Expenses7.6B8.0B8.0B11.0B
 
 
 
 
 
Research And Development1.3B1.4B1.4B2.1B
 
 
 
 
 
Total Operating Expenses17.3B17.5B17.6B25.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.9B2.9B3.2B2.1B
 
 
 
 
 
Extraordinary Credit0.0079.0M----
 
 
Extraordinary Charge-346.0M-206.0M-112.0M-362.0M
 
 
 
 
 
Interest Expense On Debt177.0M193.0M326.0M925.0M
 
 
 
 
 
Other Expenses35.0M434.0M-1.5B1.2B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.5B3.2B1.4B2.2B
 
 
 
 
 
Income Taxes-797.0M-577.0M-350.0M-1.9B
 
 
 
 
 
Discontinued Operations563.0M65.0M321.0M124.0M
 
 
 
 
 
Extraordinary Items0.001.8B16.0M0.00
 
 
 
Net Income2.3B2.7B1.4B468.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5B1.5B1.5B1.7B
 
 
 
 
 
Shares To Calculate EPS Diluted1.5B1.5B1.5B1.7B
 
 
 
 
 
 
Earnings Per ShareEPS$1.49$2.92$0.94$0.27
 
 
 
 
 
EPS Diluted$1.49$1.76$0.93$0.27